Literature DB >> 21484125

Successful liver transplantation for Rendu-Weber-Osler disease, a single centre experience.

Murat Cag1, Maxime Audet, Anne-Catherine Saouli, Murad Odeh, Bernard Ellero, Tullio Piardi, Marie-Lorraine Woehl-Jaeglé, Jacques Cinqualbre, Philippe Wolf.   

Abstract

UNLABELLED: BACKROUNDS/
PURPOSE: Hereditary hemorrhagic telangiectasia or Rendu-Weber-Osler is an autosomal dominant inherited disorder characterized by arteriovenous malformations and telangiectasia that may affect the nose, skin, lungs, brain and gastrointestinal tract. Liver involvement of the disease has been described to be responsible of biliary tract necrosis, high cardiac output and portal hypertension, due to intra-hepatic vascular shunts. We aimed to present four cases of successful orthotopic liver transplantations in this indication performing our modified Piggy-back technique. PATIENTS AND METHODS: Between 2002 and 2008, four patients have been diagnosed for Rendu-Weber-Osler disease and underwent liver transplantation. Three of them suffered from high cardiac output with heart failure, two presented HBV infection and one patient suffered from renal failure requiring a liver-kidney transplantation. We performed our modified Piggy-back technique for liver implantation, which consists to clamp selectively the hepatic veins during the hepatectomy, without venous bypass, the retro-hepatic vena cava is preserved.
RESULTS: No hemodynamic concerns disturbed the surgery and no massive transfusions were needed. The liver replacement corrected the cardiac insufficiency due to high cardiac output for the three patients. At present, the four patients are getting well.
CONCLUSIONS: Despite new advances in immunotherapy for the medical treatment of Rendu-Weber-Osler disease, liver transplantation remains the curative option for hepatic based-hereditary hemorrhagic telangiectasia.

Entities:  

Year:  2011        PMID: 21484125     DOI: 10.1007/s12072-011-9259-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  30 in total

1.  Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia.

Authors:  J H Whiting; J R Korzenik; F J Miller; J S Pollack; R I White
Journal:  J Vasc Interv Radiol       Date:  2000 Jul-Aug       Impact factor: 3.464

2.  Orthotopic liver transplantation with preservation of the inferior vena cava.

Authors:  A Tzakis; S Todo; T E Starzl
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

3.  Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation.

Authors:  C Hillert; D C Broering; M Gundlach; W T Knoefel; J R Izbicki; X Rogiers
Journal:  Liver Transpl       Date:  2001-03       Impact factor: 5.799

4.  Orthotopic liver transplantation with preservation of the caval and portal flows. Technique and results in 62 cases.

Authors:  D Cherqui; J Y Lauzet; N Rotman; C Duvoux; D Dhumeaux; M Julien; P L Fagniez
Journal:  Transplantation       Date:  1994-10-15       Impact factor: 4.939

5.  Liver disease in patients with hereditary hemorrhagic telangiectasia.

Authors:  G Garcia-Tsao; J R Korzenik; L Young; K J Henderson; D Jain; B Byrd; J S Pollak; R I White
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

6.  Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia: hemodynamic study.

Authors:  F Le Corre; B Golkar; C Tessier; J Kavafyan; J Marty
Journal:  J Clin Anesth       Date:  2000-06       Impact factor: 9.452

7.  Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation.

Authors:  U P Neumann; M Knoop; J M Langrehr; H Keck; W O Bechstein; H Lobeck; T Vogel; P Neuhaus
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

8.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

Authors:  Andrew Mitchell; Leon A Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Driesen; Luc Delriviere
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

9.  Hereditary haemorrhagic telangiectasia and secondary biliary cirrhosis.

Authors:  A Mendoza; S Oliff; E Elias
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-10       Impact factor: 2.566

10.  Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia.

Authors:  T Bauer; P Britton; D Lomas; D G Wight; P J Friend; G J Alexander
Journal:  J Hepatol       Date:  1995-05       Impact factor: 25.083

View more
  2 in total

Review 1.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

Review 2.  Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Authors:  Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.